Listed are Studies supported by InCROM since 2015
(majority conducted at Heishinkai Medical Corporation sites)
Year | Therapeutic Area | Phase | Population | No. of Subjects (Site) |
No. of Subjects (Protocol Total) |
No. of Visit |
Study Duration |
Study Site |
2024 | COVID-19 | III | Healthy males and females over 18 years of age | 293 | 2,000 (Multi Site) |
6 | 365 days | OPHAC Hospital |
2024 | COVID-19 | III | Healthy males and females over 18 years of age | 273 | 2,000 (Multi Site) |
6 | 365 days | OCROM Clinic |
2024 | COVID-19 | III | Healthy males and females over 18 years of age | 234 | 2,000 (Multi Site) |
6 | 365 days | ToCROM Clinic |
2023 | COVID-19 | III | Healthy males and females over 18 years of age | 312 | 2,000 (Multi Site) |
7 | 365 days | OPHAC Hospital |
2023 | COVID-19 | III | Healthy males and females over 18 years of age | 200 | 2,000 (Multi Site) |
7 | 365 days | OCROM Clinic |
2023 | COVID-19 | III | Healthy males and females over 18 years of age | 288 | 2,000 (Multi Site) |
7 | 365 days | ToCROM Clinic |
2023 | COVID-19 | III | Healthy males and females over 18 years of age | 61 | 850 (Multi Site) |
5 | 181 days | OPHAC Hospital |
2023 | COVID-19 | III | Healthy males and females over 18 years of age | 74 | 850 (Multi Site) |
5 | 181 days | OCROM Clinic |
2023 | COVID-19 | III | Healthy males and females over 18 years of age | 71 | 850 (Multi Site) |
5 | 181 days | ToCROM Clinic |
2023 | COVID-19 | I / II | Males and females 18 to 64 years of age and eldarly males and females 65 to 75 years of age |
Part 1 : 96 Part 2 : 108 |
396 (Multi Site) |
Part 1 : 9 Part 2 : 8 |
365 days | OPHAC Hospital |
2023 | COVID-19 | I / II | Males and females 18 to 64 years of age and eldarly males and females 65 to 75 years of age |
109 | 396 (Multi Site) |
9 | 365 days | OCROM Clinic |
2023 | COVID-19 | I / II | Males and females 18 to 64 years of age and eldarly males and females 65 to 75 years of age |
106 | 396 (Multi Site) |
9 | 365 days | ToCROM Clinic |
2023 | COVID-19 | III | Healthy males and females over 18 years of age | 100 | 780 (Multi Site) |
6 | 361 days | OPHAC Hospital |
2023 | COVID-19 | III | Healthy males and females over 18 years of age | 110 | 780 (Multi Site) |
6 | 361 days | ToCROM Clinic |
2023 | COVID-19 | III | Healthy males and females 12 to 17 years of age | 5 | 450 (Multi Site) |
6 | 393 days | OPHAC Hospital |
2023 | COVID-19 | III | Healthy males and females 12 to 17 years of age | 5 | 450 (Multi Site) |
6 | 393 days | ToCROM Clinic |
2022 | Pneumococcal Conjugate | III | Eldarly males and females over 65 years of age | 70 | 440 (Multi Site) |
2 | 30 days | OPHAC Hospital |
2022 | Pneumococcal Conjugate | III | Eldarly males and females over 65 years of age | 70 | 440 (Multi Site) |
2 | 30 days | OCROM Clinic |
2022 | Pneumococcal Conjugate | III | Eldarly males and females over 65 years of age | 70 | 440 (Multi Site) |
2 | 30 days | ToCROM Clinic |
2022 | COVID-19 | II | Males and females 18 to 55 years of age and eldarly males and females over 65 years of age |
55 (18 to 55 years of age) 55 (over 65 years of age) |
300 (Multi Site) |
9 | 365 days | OPHAC Hospital |
2022 | COVID-19 | III | Healthy males and females 18 to 40 years of age | 40 | 1,500 (Global / Multi Site) |
10 | 483 days | OCROM Clinic |
2022 | Others | I | Healty males and females 20 to 64 years of age | 20 | 20 | 7 | 120 days | OPHAC Hospital |
2022 | COVID-19 | I | Males and females 18 to 55 years of age and eldarly males and females over 65 years of age |
46 (18 to 55 years of age) 46 (over 65 years of age) |
92 | 9 | 365 days | OPHAC Hospital |
2021 | COVID-19 | I / II | Males and females over 18 years of age | 115 | 2,000 (Multi Site) |
8 | 503 days | OPHAC Hospital |
2021 | COVID-19 | I / II | Males and females over 18 years of age | 115 | 2,000 (Multi Site) |
8 | 503 days | OCROM Clinic |
2021 | COVID-19 | I / II | Males and females over 18 years of age | 190 | 2,000 (Multi Site) |
8 | 503 days | ToCROM Clinic |
2021 | Respiratory Syncytial | III | Eldarly males and females over 60 years of age | 50 | 30,000 (Global / Multi Site) |
4 | – | OPHAC Hospital |
2021 | COVID-19 | I / II | Males and females over 20 years of age | 32 | 145 (Multi Site) |
8 | 386 days | OPHAC Hospital |
2021 | COVID-19 | I / II | Males and females over 20 years of age | 44 | 145 (Multi Site) |
8 | 386 days | OCROM Clinic |
2021 | COVID-19 | I / II | Males and females over 20 years of age | 51 | 145 (Multi Site) |
8 | 386 days | ToCROM Clinic |
2021 | COVID-19 | I / II | Healty males and females 18 to 65 years of age | 57 | 240 (Multi Site) |
12 (including hospitalisation) | 394days | OPHAC Hospital |
2021 | COVID-19 | I / II | Healty males and females 18 to 65 years of age | 115 | 240 (Multi Site) |
9 | 394days | ToCROM Clinic |
2021 | COVID-19 | I / II | Males and females over 18 years of age | 91 | 400 (Multi Site) |
11 | 365days | OPHAC Hospital |
2021 | COVID-19 | I / II | Males and females over 18 years of age | 79 | 400 (Multi Site) |
11 | 365days | OCROM Clinic |
2021 | COVID-19 | I / II | Males and females over 18 years of age | 63 | 400 (Multi Site) |
11 | 365days | ToCROM Clinic |
2021 | Pneumococcal conjugate | III | Eldarly males and females over 60 years of age | 70 | 400 (Multi Site) |
3 | 56days | OPHAC Hospital |
2021 | Pneumococcal conjugate | III | Eldarly males and females over 60 years of age | 146 | 400 (Multi Site) |
3 | 56days | OCROM Clinic |
2021 | Pneumococcal conjugate | III | Eldarly males and females over 60 years of age | 136 | 400 (Multi Site) |
3 | 56days | ToCROM Clinic |
2020 | COVID-19 | I / II | Males and females 20 to 64 years of age | 60(Ph1) | 214 (Multi Site) |
13 | 386 days | OPHAC Hospital |
2020 | COVID-19 | II / III | Males and females over 18 years of age | 80 | 500 (Multi Site) |
7 | 365 days | OPHAC Hospital |
2020 | COVID-19 | II / III | Males and females over 18 years of age | 90 | 500 (Multi Site) |
7 | 365 days | OCROM Clinic |
2020 | COVID-19 | II / III | Males and females over 18 years of age | 80 | 500 (Multi Site) |
7 | 365 days | ToCROM Clinic |
2020 | Influenza | III | Males and females over 60 years of age | 320 | 2,100 (Multi Site) |
2 | 28 days | OPHAC Hospital |
2020 | Influenza | III | Males and females over 60 years of age | 350 | 2,100 (Multi Site) |
2 | 28 days | OCROM Clinic |
2020 | Influenza | III | Males and females over 60 years of age | 350 | 2,100 (Multi Site) |
2 | 28 days | ToCROM Clinic |
2020 | Influenza | III | Males and females over 60 years of age | 180 | 2,100 (Multi Site) |
2 | 28 days | Other Medical Iinstitutions |
2020 | Others | III | Healthy males 20 to 45 years of age | 100 | 900 (Multi Site) |
10 | 42 days | OPHAC Hospital |
2020 | Others | I | Healty males and females 10 to 54 years of age | 214 | 360 (Multi Site) |
2 | 30 days | ToCROM Clinic |
2020 | Others | I | Healty males and females 10 to 54 years of age | 106 | 360 (Multi Site) |
2 | 30 days | Other Medical Iinstitutions |
2018 | Others | I | Healty males 20 to 39 years of age | 60 | 60 | 2 | 43 days | OPHAC Hospital |
2018 | Influenza | III | Healty males and females 13 to 64 years of age | 215 (under 19 of age) 535 (over 20years of age) |
1,500 (Multi Site) |
3 | 180 days | OPHAC Hospital |
2019 | Others | III | Healthy eldarly males and females over 65 years of age | 50 | 240 (Multi Site) |
2 | 30 days | OPHAC Hospital |
2017 | Influenza | II | Males and females over 13 years of age | 50 (13 to 19 years of age) 100 (20 to 64years of age) 100 (over 65years of age) |
500 (Multi Site) |
5 | 180 days | OPHAC Hospital |
2017 | Influenza | II | Males and females over 13 years of age | 50 (13 to 19 years of age) 100 (20 to 64years of age) 100 (over 65years of age) |
500 (Multi Site) |
5 | 180 days | ToCROM Clinic |
2017 | Influenza | I / II | Eldarly males and females over 65 years of age | 85 | 175 (Multi Site) |
3 | 28 days | OCROM Clinic |
2017 | Influenza | I / II | Eldarly males and females over 65 years of age | 90 | 175 (Multi Site) |
3 | 28 days | ToCROM Clinic |
2016 | Influenza | I | Healthy males 20 to 49 years of age | 90 | 90 | 1 nt 2 days x 2 + 5 visits | 56 days | OPHAC Hospital |
2016 | Influenza | II | Healty males and females 20 to 64 years of age | 300 | 600 (Multi Site) |
3 | 43 days(180 days) | OPHAC Hospital |
2016 | Influenza | I | Healty males 20 to 39 years of age and eldarly males and females over 65 years of age |
60 (20 to 39 years of age) 60 (over 65years of age) |
120 | 5 | 180 days | OPHAC Hospital |
2015 | Influenza | I | Healty males and females 20 to 64 years of age | 120 | 120 | 7 | 21 days(180 days) | OPHAC Hospital |